SCHEMBL15048938

SCHEMBL15048938

C[C@@H]1CCCC[C@@]1(O)C#C[Si](C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15049525 1.00 MAPT (0.30) MAPT
SCHEMBL15048978 1.00 MAPT (0.30) MAPT
SCHEMBL15048950 1.00 MAPT (0.30) MAPT
SCHEMBL30809923 0.77
SCHEMBL15048981 0.77
SCHEMBL15049077 0.77
SCHEMBL15048975 0.77
SCHEMBL15048812 0.77
SCHEMBL15049045 0.77 MAPT (0.32) MAPT
SCHEMBL15049281 0.77 MAPT (0.32) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2794566-A1 PIPECOLATE-DIKETOAMIDES FOR TREATMENT OF PSYCHIATRIC DISORDERS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-10-29 EP disclosed
WO-2013091900-A1 PIPECOLATE-DIKETOAMIDES FOR TREATMENT OF PSYCHIATRIC DISORDERS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2013-06-27 WO disclosed
EP-2607352-A1 Pipecolate-diketoamides for treatment of psychiatric disorders Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2013-06-26 EP disclosed